Co‑injecting three common amino acids with LNPs dramatically boosted both mRNA delivery and CRISPR gene editing efficiency in preclinical models.
Better mRNA release inside cells boosts vaccine and gene editing performance, enabled by redesigned lipid molecules that grip ...
Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...
Simple ‘cocktail’ of amino acids dramatically boosts power of mRNA therapies and CRISPR gene editing
Lipid nanoparticles, or LNPs, are best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of ...
With rapid advances in in vivo CAR‑T, gene editing, and cancer immunotherapy – alongside headline‑making acquisitions such as Eli Lilly & Orna, BMS & Orbital, AbbVie & Capstan, and BioNTech & CureVac ...
Increasing the efficiency of LNPs as therapeutic vehicles offers promise for better mRNA-based and gene editing treatment success.
CRISPR gene editing has revolutionized the field of molecular biology, offering precise, efficient, and versatile tools for genome modification. The technology has rapidly evolved beyond the original ...
Prof. Lukas Dow, biochemistry, and his team published a study in Nature on Aug. 16, detailing a new, more specific gene editing tool that they created to study cancer mutations through preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results